Dong Meng

Dong Meng

Auto-generated profile, based on publicly available information

Dong Meng

Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, PR China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in Nanomedicine
Verified
Journal Article
Closed access
DMDong Meng
Dong Meng
LGLu Guo
Lu Guo
DSDandan Shi
Dandan Shi
XSXiao Sun
Xiao Sun
MSMengmeng Shang
Mengmeng Shang
JLJie Li
Jie Li
Aim: O-carboxymethyl chitosan/perfluorohexane nanodroplets (O-CS NDs) and doxorubicin-loading O-carboxymethyl chitosan nanodroplets were synthesized and functionally tested as drug delivery system ... Graphical abstract

21 November 2019 in Nanomedicine
Verified
Journal Article
Closed access
LGLu Guo
Lu Guo
DSDandan Shi
Dandan Shi
DMDong Meng
Dong Meng
MSMengmeng Shang
Mengmeng Shang
XSXiao Sun
Xiao Sun
JLJie Li
Jie Li
Aim: To synthesize and evaluate a novel FH peptide-modified ultrasonic nanobubble-loading doxorubicin (FH-NB-DOX) for specially cancer-associated fibroblasts (CAFs) targeting and eradication. Materials & methods: The characteristics, cytotoxicity, contrast-enhanced ultrasound imaging (CEUI), targeting ability and specially eradicating CAFs of these NBs were investigated. Results: FH-NB-DOX (about 208 nm) showed a good CEUI, and achieved higher targeting ability due to the conjunction ability of FH peptide to tenascin C protein high-level expressed in CAFs. Under ultrasound irradiation, FH-NB-DOX could delivery more DOX into CAFs, thus exhibited stronger eradication role compared with NB-DOX and free DOX. Conclusion: These new NBs, which combines the advantages of targeted theranostic agent and CEUI, is expected to be a potential approach for tumor therapy based on CAF targeting.